PubRank

J R Azanza

Author PubWeight™ 9.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Transpl Infect Dis 2014 1.41
2 Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study. Rev Esp Quimioter 2007 0.97
3 Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007 0.94
4 Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionization mass spectrometry. Illustration using an assay method for the determination of famotidine in human plasma. J Chromatogr B Biomed Sci Appl 2001 0.87
5 Clinical relevance of sirolimus drug interactions in transplant patients. Transplant Proc 2004 0.87
6 Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome. Clin Microbiol Infect 2004 0.85
7 Oral availability of bilastine. Clin Drug Investig 2013 0.85
8 Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998 0.81
9 [Zanamivir: new therapeutic option for influenza]. Rev Med Univ Navarra 2000 0.78
10 Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993 0.78
11 [Recommendations of antifungal treatment in patients with low grade immunosuppression]. Rev Esp Quimioter 2008 0.78
12 [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients]. Rev Med Univ Navarra 1991 0.75
13 [Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections]. Rev Med Univ Navarra 1989 0.75
14 [Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)]. Rev Med Univ Navarra 1995 0.75
15 [Irbesartan]. Rev Med Univ Navarra 1999 0.75
16 Concurrent clarithromycin and cyclosporin A treatment. J Antimicrob Chemother 1998 0.75
17 [Sequential treatment with fluoroquinolones]. Enferm Infecc Microbiol Clin 1999 0.75
18 Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS). Actas Esp Psiquiatr 2007 0.75
19 [Telithromycin: a new therapeutic option for community-acquired respiratory infection]. Rev Med Univ Navarra 2003 0.75
20 [Celiprolol]. Rev Med Univ Navarra 1991 0.75
21 [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Rev Med Univ Navarra 1993 0.75
22 [Pharmacologic surveillance outside the hospital: necessity and methods]. Rev Med Univ Navarra 1989 0.75
23 201Tl myocardial imaging in a cardiac rejection episode. Eur J Nucl Med 1986 0.75
24 Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients. Biomed Chromatogr 2002 0.75
25 Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients. Int J Clin Pharmacol Res 1988 0.75
26 [Clinical experience with a new fluoroquinolone: ciprofloxacin]. Enferm Infecc Microbiol Clin 1989 0.75
27 [Triflusal]. Rev Med Univ Navarra 1982 0.75
28 A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. Atherosclerosis 1991 0.75
29 [Study of vasoconstrictors in dental anesthetic solutions]. Arch Odonto Estomatol 1988 0.75
30 [Double-blind parallel clinical trial with tenoxicam in comparison with indomethacin in the treatment of rheumatoid arthritis]. Rev Med Univ Navarra 1984 0.75
31 [Pharmacoeconomics. Fact or fiction?]. Rev Med Univ Navarra 1998 0.75
32 [Itraconazole++-induced neurotoxicity]. Med Clin (Barc) 1992 0.75
33 [Fexofenadine: a antihistaminic. Review of its practical characteristics]. Rev Med Univ Navarra 2001 0.75
34 [Voriconazole]. Rev Med Univ Navarra 2003 0.75
35 [Relationship between structure and function in the azoles]. Rev Esp Quimioter 2004 0.75
36 [Quinupristin/dalfopristin]. Rev Med Univ Navarra 2002 0.75
37 [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis]. Rev Esp Quimioter 2010 0.75
38 Cimetidine does not alter sparfloxacin pharmacokinetics. Int J Clin Pharmacol Ther 1995 0.75
39 [Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)]. Rev Med Univ Navarra 2004 0.75
40 Rapid high-performance liquid chromatographic determination of cefepime in human plasma. Biomed Chromatogr 1999 0.75
41 [Tiotropium]. Rev Med Univ Navarra 2004 0.75
42 [Treatment with tacrolimus in autoimmune diseases]. Rev Med Univ Navarra 2004 0.75
43 [Minaprine]. Rev Med Univ Navarra 1984 0.75
44 [Levofloxacin]. Rev Med Univ Navarra 1999 0.75
45 [Guidelines for empirical antibiotic treatment of intraabdominal infections. Spanish Society of Chemotherapy]. Rev Esp Quimioter 2000 0.75
46 Ziprasidone: from pharmacology to the clinical practice. One year of experience. Actas Esp Psiquiatr 2005 0.75
47 [The most common infections in the transplanted patient]. An Sist Sanit Navar 2006 0.75
48 [New perspectives in immunosuppression]. Nefrologia 2005 0.75
49 [Phase I study of a tolmetin-paracetamol (AU-8001) ester]. Rev Med Univ Navarra 1989 0.75